Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes

A Randomized Translational Study to Examine the Effects of Shared Care Versus Usual Care in Management of Gestational Diabetes in a Three-tier Prenatal Care Network in Tianjin, China

Research question (s)/hypothesis:

  1. . The effectiveness of the shared care management of gestational diabetes mellitus;
  2. . The cost-effectiveness of the shared care management;
  3. . Its sustainability

Studieoversigt

Detaljeret beskrivelse

Method (s) Tianjin three-tier antenatal care network established a universal screening program for gestational diabetes mellitus (GDM) in 1998 and up to 2008, the screening program had screened 115348 pregnant women. GDM will be defined as either fasting plasma glucose (PG) ≥5.1 mmol/L or 1-hour PG≥ 10.0 mmol/L or 2-hour PG≥ 8.5 mmol/L after 75 g glucose tolerance test. A total of 920 pregnant women who have GDM and agree to participate will be randomly assign to have the shared care (diet, physical activity and insulin if indicated) or the local usual antenatal care. The sample size has ≥80% power at a 5% type I error to detect the difference in the primary endpoint, birth weight ≥4000 gram and the secondary endpoint, pregnancy-induced hypertension. Hyperglycemia and other clinical data in the two groups of women will be collected during the shared care or the usual care. Logistic regression and cost-effectiveness analysis will be used in the data analysis.

Public health significance: The introduction of the proven management of GDM in Tianjin antenatal care network will justify the universal screening for GDM and reduce the rate of macrosomic infants and reduce pregnancy-induced hypertension, and thus improve pregnancy outcomes of women with GDM.

Sustainability plan: Just as the universal GDM screening in 1998, the shared care model will be introduced into the Tianjin antenatal care network as part of the usual care routine after the proposed study. The success of the care model will also be publicized and expanded to suburban districts and rural counties of Tianjin, possibly other parts of world where universal screening for GDM is a routine practice.

ACKNOWLEDGEMENT This project is supported by a BRIDGES grant from the International Diabetes Federation. BRIDGES, an International Diabetes Federation project, is supported by an educational grant from Lilly Diabetes."

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

948

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Tianjin
      • Tianjin, Tianjin, Kina
        • Tianjin Women and Children's Health Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 50 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • All pregnant women who are diagnosed to have GDM.

Exclusion Criteria:

  • Diagnosis of overt diabetes during OGTT;
  • Younger than 18 years of age;
  • Non-singleton pregnancy;
  • Maternal-foetal ABO blood type incompatibility;
  • Maternal diseases such as chronic hypertension,thyrotoxicosis, prepregnancy diabetes and use of long-term medications that may affect glucose metabolism.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: The usual care arm
  • Individualized dietary and physical activity consultation plus group diabetes education
  • Self blood glucose monitoring
  • Insulin therapy if indicated
  • Self blood glucose monitoring
  • Insulin therapy institutions if indicated;
Andre navne:
  • The shared lifestyle intervention arm
Aktiv komparator: The shared care arm
  • Individualized dietary and physical activity consultation plus group diabetes education
  • Self blood glucose monitoring
  • Insulin therapy if indicated
  • Self blood glucose monitoring
  • Insulin therapy institutions if indicated;
Andre navne:
  • The shared lifestyle intervention arm

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The Rate of Macrosomia.
Tidsramme: At the time of birth.
Macrosomia is defined as birthweight ≥ 4000 gram.
At the time of birth.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The Rate of Pregnancy-induced Hypertension.
Tidsramme: From enrolment at 24-28 gestational weeks till after delivery, an average of 12 weeks.
Pregnancy-induced hypertension includes gestational hypertension and preeclampsia/eclampsia.
From enrolment at 24-28 gestational weeks till after delivery, an average of 12 weeks.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studiestol: Gongshu Liu, MD, Women and Children's Health Center

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2010

Primær færdiggørelse (Faktiske)

1. juni 2013

Studieafslutning (Faktiske)

1. september 2013

Datoer for studieregistrering

Først indsendt

21. marts 2012

Først indsendt, der opfyldte QC-kriterier

27. marts 2012

Først opslået (Skøn)

28. marts 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

7. juli 2015

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. juni 2015

Sidst verificeret

1. juni 2015

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Svangerskabsdiabetes mellitus

Abonner